Figure 11.
Time-dependent antiproliferative assay of (a) irinotecan, (b) gemcitabine, (c) epirubicin, (d) dasatinib, (e) doxorubicin, (f) etoposide, (g) paclitaxel, (h) camptothecin, (i) fludarabine, and (j) clofarabine in the absence and presence of [W5R4C]–SeNPs. The experiments were conducted in triplicate (n = 3).
